For over 25 years we have supported hundreds of clients in more than 25 countries worldwide. For further information please contact us at . Or just click one of the buttons to find out what
Our organization is structured per discipline, offering our broad palette of services to the (bio) pharmaceutical, medical device and healthcare fields. The headquarters is located in Leiden, The Netherlands with additional offices in Berlin, Germany and Stockholm, Sweden and we have representations in the United Kingdom and Japan.
Arthemius v.o.f. was founded, to bring additional expertise for the biotechnology sector.Read more
Helix Engineering B.V. starts
New activities are employed by starting VipQuip B.V., offering services on metrology and calibration.
Xendo Laboratories B.V., a bioanalytical contract laboratory is founded in Groningen.Read more
The company headquarters move from Amsterdam to the Bio Science Park Leiden.
Helix Engineering B.V. changes to
Vipquip B.V. changes to
Xendo Laboratories B.V. although part of
Xendo Drug Development B.V. expands with
Xendo Drug Development B.V., a 100% subsidiary of
Quality Engineering, a business unit of
Xendo Clinics B.V. opens a second 14-bed Clinical Pharmacology Unit for phase I/IIa clinical research on the premises of the University Medical Centre Groningen.Read more
As of January 1st, 2006,
Xendo Drug Development B.V.
Xendo Manufacturing B.V.
Xendo Pharma Services B.V.
Xendo B.V. forms a joint venture with the University Medical Center Groningen. The joint venture,
The Groningen site expands its clinical research portfolio offering (temporary) contract research services in support of phase II – IV studies with drug and medical device candidates. These services are offered through a new division named
The Leiden site realigns its structure to better serve our customers. Three divisions were formed, creating a maximal synergy:
Xendo Pharma Services
Xendo Regulatory Affairs
As per July
Xendo BV and Batavia Bioservices BV have initiated a strategic business collaboration. As a consequence, all Bioprocess activities of Xendo Manufacturing BV have been transferred to Batavia Bioservices BV. Through this
Xendo BV has acquired the Vigilex Group allowing Xendo BV to further expand its palette of services with pharmacovigilance activities and at the same time have new branches in the United Kingdom and Japan.Read more
Sovereign Capital, the UK private equity Buy & Build specialist, has completed the management buy-out of Xendo BV. Sovereign has partnered the management team to further develop the business through a strategy of organic and acquisitive growth.Read more